glp-1 news today oct 2 2025 ISPOR 2025: Exploring reasons for discontinuation GLP-1 therapies are changing obesity

Following a consistent schedule helps maintain a steady level of the medication in your body, which supports more stable appetite control and blood sugar management

That said, the combination has not been tested for safety or effect in a human trial, so "can" here means chemically formulated together, not clinically validated

Recent studies from our laboratory have shown that expression of IKK and TBK1, non-canonical members of the IKK family of protein kinases, are up-regulated in adipose tissues of obese or aged mice, associated with insulin resistance and repression of energy expenditure

Behavioral Strategies for Relief Sometimes, how you eat is just as important as what you eat

Research suggests that tesamorelin may help elderly patients suffering from dementia

M.MostafaM.MadyF